Spinal Tech

Full-year 2020 revenue for SeaSpine declined 3 percent year over year to between $154.1 million and $154.5 million, according to a preliminary unaudited report released Jan. 11.

The FDA granted clearance of 40 orthopedic and spine devices in December.

Pacira Biosciences reported a record revenue of $429.6 million last year, according to a Jan. 7 news release.

From two big-money acquisitions in the orthopedic space to a new CEO entering the fray, here is the latest device company news:

Full-year 2020 revenue for SI-Bone, a sacropelvic device company, increased 9 percent to between $73.1 million and $73.4 million year over year, according to a preliminary unaudited report on Jan. 7.

Laura Francis, SI-Bone's CFO and COO, has been unveiled as the next CEO of the sacropelvic device company.

Parvizi Surgical Innovation, a company owned by orthopedic surgeon Javad Parvizi, MD, has invested in a software company focused on medical grade virtual reality and augmented reality technology for surgical training.

Arthrodesis, a company owned by Rama Chandran, MD, is suing Wright Medical for patent infringement.

NuVasive's stock rose 5.8 percent Jan. 6 after publication of its study regarding single-position spine surgery in The Spine Journal, according to Seeking Alpha.

Here's how Medtronic, Stryker and Johnson & Johnson's shares have fluctuated over the last five days.